Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
Go back to Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 326.89 -4.61 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $331.50 | 52 Week High | $141.32 | |||
| Open | $328.00 | 52 Week Low | $97.79 | |||
| Day High | $330.56 | P/E | 52.30 | |||
| Day Low | $326.16 | EPS | $6.25 | |||
| Volume | 438,652 | |||||
